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ABSTRACT 
PURPOSE: To examine the visual predictors of falls and injurious falls among older 
adults with glaucoma. 
METHODS:  Prospective falls data were collected for 71 community-dwelling adults 
with primary open-angle glaucoma, mean age 73.9 ± 5.7 years, for one year using 
monthly falls diaries.  Baseline assessment of central visual function included high-
contrast visual acuity and Pelli-Robson contrast sensitivity.  Binocular integrated 
visual fields were derived from monocular Humphrey Field Analyser plots.  Rate 
ratios (RR) for falls and injurious falls with 95% confidence intervals (CIs) were 
based on negative binomial regression models. 
RESULTS:  During the one year follow-up, 31 (44%) participants experienced at 
least one fall and 22 (31%) experienced falls that resulted in an injury.  Greater 
visual impairment was associated with increased falls rate, independent of age and 
gender.  In a multivariate model, more extensive field loss in the inferior region was 
associated with higher rate of falls (RR 1.57, 95%CI 1.06, 2.32) and falls with injury 
(RR 1.80, 95%CI 1.12, 2.98), adjusted for all other vision measures and potential 
confounding factors.  Visual acuity, contrast sensitivity, and superior field loss were 
not associated with the rate of falls; topical beta-blocker use was also not associated 
with increased falls risk.   
CONCLUSIONS:  Falls are common among older adults with glaucoma and occur 
more frequently in those with greater visual impairment, particularly in the inferior 
field region.  This finding highlights the importance of the inferior visual field region in 
falls risk and assists in identifying older adults with glaucoma at risk of future falls, for 
whom potential interventions should be targeted. 
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INTRODUCTION  
Falls are a major cause of injury, healthcare utilization and mortality among older 
adults.1-3  Approximately one in three adults aged over 65 years experience at least 
one fall each year, and one-half of these experience multiple falls.1, 4, 5  The ability to 
safely navigate through complex environments is highly dependent on visual input, in 
order to enable effective path planning and obstacle avoidance,6, 7  and visual 
impairment  has been shown to be an important contributing factor for falls and 
fractures among older adults.4, 5, 8-12   
Binocular visual field loss, regardless of its cause, has been shown to be the leading 
visual risk factor for falls and fractures among older community-dwelling 
populations.4, 5, 8  Glaucoma is the leading cause of irreversible visual field loss 
among older adults,13 and has been associated with higher rates of falls,9, 14-16 hip 
fractures10 or fall-related hospitalizations17 compared to those with normal vision. In 
support of this, visual field loss has been linked to slower walking speeds and 
increased obstacle contacts in mobility studies, both in general older populations,18 
and among those with glaucomatous visual impairment.19, 20  Furthermore, visual 
field loss among older adults with glaucoma has been linked to greater postural 
instability,21 which may further increase the risk of falls.22  Other studies, however, 
have failed to show that glaucoma is associated with increased falls risk.11, 23, 24 
These disparate findings may be attributed to the considerable variations in study 
designs, sample populations, definitions of falls and data collection methods in these 
studies.  
Importantly, the pattern of glaucomatous visual field loss differs to that of other eye 
diseases, as it reflects the distribution of the retinal nerve fibers.  Defects are slightly 
more common in the superior than the inferior hemifield, and individuals with bilateral 
glaucoma often present with defects in the same hemifield in both eyes.25  This 
pattern of visual field defects has important functional implications, as the inferior 
visual field region has been shown to be essential for safe navigation, as 
demonstrated by mobility studies involving individuals with visual impairment from a 
range of eye diseases18, 26 as well as those involving participants with simulated 
visual impairment.7  A population study of community-dwelling older adults by 
Freeman and colleagues5 assessed the independent contributions of field loss 
location on prospective falls, however neither the superior nor inferior field areas 
were found to be stronger predictors in their multivariate models.   
Studies also suggest that topical anti-glaucoma medication use, particularly beta-
blockers, may increase the likelihood of falls.9, 23  These studies, however, are limited 
as the comparison groups did not use any form of topical anti-glaucoma medications, 
and were therefore unlikely to have glaucoma or visual field loss.  In contrast, recent 
research has shown that older adults with glaucoma using topical beta-blockers were 
no more likely to experience a previous fall, compared to glaucoma patients using 
prostaglandins.27   
The primary objective of this study was to examine which aspects of visual function 
are most highly associated with falls and injurious falls among community-dwelling 
older adults with glaucoma, particularly the impact of the location of visual field loss.  
A secondary objective was to examine whether beta-blocker use was associated 
with prospective falls in this cohort. 
METHODS: 
Participants 
Seventy-one community-dwelling individuals aged 60 years and above who were 
currently being treated for open-angle glaucoma were recruited from the clinical 
records of the Queensland University of Technology Optometry Clinic, private 
ophthalmology practices and local members of Glaucoma Australia.  Participants 
were excluded if they had any significant ocular or visual pathway disease leading to 
visual field loss, other than glaucoma; any form of cataracts graded 3.0 or worse, 
defined by the Lens Opacities Classification System III;28 suffered from Parkinson’s 
Disease; history of dizziness or vestibular disease; used a walking aid; or had signs 
of cognitive impairment (Mini-Mental State Examination score <24 of 30).29  The 
research followed the tenets of the Declaration of Helsinki, and informed consent 
was obtained before participant assessment. The study was approved by the 
Queensland University of Technology Human Research Ethics Committee. 
Demographic assessment  
Data were collected on demographic information (age and gender) and medical 
information (medical history and current medication use).  Self-reported medical and 
health conditions included arthritis, cancer, diabetes mellitus, hypertension, 
cardiovascular disease (angina, heart attack), hearing impairment, history of stoke, 
history of hip fracture, and incontinence.30  A measure of self-rated health was 
determined by asking participants to rate their own health as either excellent, very 
good, good, fair, or poor.31  The use of topical anti-glaucoma medications was 
dichotomously coded into either the use of topical medications including beta-
blockers, or the use of topical medications other than beta-blockers.  Participants 
reported the number of falls in the 12 months before participation in the study, along 
with fear of falling status using a single dichotomous question: “Are you worried or 
afraid of falling, except in a high place?”32  Participants’ habitual spectacle correction 
used for walking was coded as either multifocal (bifocals, trifocals, progressives) or 
non-multifocal (no correction, single vision, contact lenses). 
Visual function assessment 
Right and left visual acuity was measured with habitual distance refractive correction 
using a standard Bailey-Lovie high-contrast letter chart at a working distance of 6m 
with a chart luminance of 160 cd m-2.  Visual acuity was scored as the total number 
of letters read correctly, converted to logMAR units.  Right and left letter contrast 
sensitivities were measured with habitual refractive correction using the Pelli-Robson 
letter chart at 1m with a +0.75 DS working distance correction in place,33 chart 
luminance of 83 cd m-2 and scored as the number of letters correctly identified.34   
Visual fields were assessed with a computerized perimeter (Humphrey Field 
Analyzer; model HFA-II 750; Carl Zeiss Meditec Inc., Dublin, CA).  Monocular 24-2 
Swedish Interactive Threshold Algorithm (SITA)-Standard threshold tests were 
performed by an experienced optometrist.  A binocular mean deviation (MD) score 
was derived by merging the right and left fields to create an integrated visual field 
(IVF) extending 60° horizontally (IVF-60), based on the more sensitive of the two 
eyes at each visual field location.35, 36  In addition, monocular 81-point, single 
intensity (24 dB) screening strategy tests were performed and merged to create a 
96-point IVF extending 120° horizontally (IVF-120), based on the more sensitive of 
the two visual field locations in each eye, as outlined by Turano et al.18  The IVF-120 
was scored as the total number of points missed.  Points falling above and below the 
horizontal midline for the IVFs were used to determine the mean deviation scores 
(IVF-60) or points missed (IVF-120) for the superior and inferior field areas 
respectively. 
Prospective Falls Assessment  
Falls were recorded prospectively during the 12-month follow-up using monthly falls 
diaries.37  Participants were provided with a set of 12 falls diaries to return by mail to 
the study centre at the end of each month.  Participants were instructed on how to 
record the occurrence of any falls and any fall-related injuries on a daily basis in 
these diaries.  In instances where the diaries were not returned promptly, 
participants were contacted by telephone to ascertain the occurrence of any falls 
during the corresponding month.  In this study, a fall was defined as an "event which 
results in a person coming to rest inadvertently on the ground or other lower level, 
and not as a consequence of sustaining a violent blow, loss of consciousness, 
sudden onset of paralysis or epileptic seizure".38, 39   
Statistical Analysis 
Data were analysed using SPSS (version 16.0, SPSS, Chicago, IL).  Analyses were 
two-tailed, and P-values less than 0.05 were considered statistically significant.  
Descriptive statistics were calculated for demographic, medical and visual function 
data.  Negative binomial regression, which is a generalization of the Poisson 
regression,40, 41 was used to examine the association between the number of falls 
and falls that resulted in an injury and each of the visual function measures, with 
adjustment for the possible confounding effects of age and gender.  Rate ratios (RR) 
and 95% confidence interval (CI) for falls were calculated per clinically relevant unit 
reduction or around 10% reduction of the total range to provide clinically meaningful 
estimates. 
As the visual function measures were highly correlated in this glaucoma cohort, the 
visual function measures were reduced using factor analysis to remove the influence 
of multicollinearity for multivariate regression modelling.42  Visual acuity, contrast 
sensitivity and inferior and superior visual field variables were submitted to principal 
components analysis using varimax rotation to derive four orthogonal statistically 
independent factors: acuity, contrast, inferior field and superior field.  Lower factor 
scores reflected poorer visual function.  Multivariate negative binomial regression 
models were conducted to identify the specific components of vision independently 
associated with falls and injurious falls, adjusted for all vision factors.  Further 
models also adjusted for a number of potential confounding variables: age, gender, 
use of multifocal corrections, self-reported co-morbidities and self-rated health 
status. 
RESULTS: 
The mean age of the 71 participants was 73.9 ± 5.7 years (range 62 to 90) and 34 
(48%) were female.  Participants reported a mean of 2.1 ± 1.4 co-morbidities; the 
most common conditions were arthritis (51%), hearing impairment (39%), 
hypertension (39%), heart disease (29%) and history of cancer (27%).  Twenty-four 
(34%) participants reported one or more falls in the previous year and 16 (23%) 
reported fear of falling.  The glaucoma medical history and visual function 
characteristics of the participants are presented in Table 1.  The severity of 
glaucomatous visual impairment based on the extent of visual field loss, ranged from 
early to advanced, with IVF-60 MD scores of -4.10 ± 6.28 dB (range -28.23 to 1.59) 
and IVF-120 points missed 32 ± 21 (range 6 to 96).   
At follow-up, 31 (44%) participants reported one or more falls; 17 (24%) fell only 
once, while 14 (20%) fell two or more times (up to a maximum of 9 falls).  Twenty-
two (31%) participants reported one or more injurious falls, all of which resulted in 
soft tissue injuries (bruises, abrasions, and sprains of the upper and lower limb).  No 
serious fall-related injuries were reported.   
The association between the vision measures and falls and injurious falls, adjusted 
for age and gender, are presented in Table 2.  Greater reduction in visual function 
across all of the vision measures was associated with an increased rate of falls.  The 
better-eye measures of visual acuity and contrast sensitivity were better predictors of 
falls than the worse-eye measures.  For both of the visual field measures, greater 
binocular inferior visual field loss was the strongest predictor of falls.  Each 5 dB 
reduction in the inferior IVF-60 at baseline was associated with a 56% higher rate of 
falls during the 12-month follow-up (RR 1.56, 95%CI 1.22, 1.99), while 10 points 
missed in the inferior IVF-120 at baseline was associated with a 62% higher rate of 
falls during the 12-month follow-up (RR 1.62, 95%CI 1.23, 2.14).  The inferior visual 
field measures were the only visual function measures significantly associated with 
injurious falls.  Participants using topical beta-blocker medications had a lower rate 
of falls (RR 0.76, 95%CI 0.39, 1.48) and injurious falls (RR 0.57, 95%CI 0.24, 1.37) 
than those not using these medications, although these estimates did not reach 
significance. 
The regression models were also examined to specifically explore whether one 
visual field strategy was superior to the other in terms of predicting falls and injurious 
falls outcomes.  There were no significant differences in goodness of fit between 
models which included the full-field IVF-60 or full-field IVF-120, or between models 
which included the inferior IVF-60 or inferior IVF-120 (differences in Akaike’s 
Information criterion values < 2; Vuong Non-Nested Test, p>0.05).43, 44 
The loadings of the vision variables used to generate the four vision factors are 
shown in Table 3.  In the multivariate models including all vision factors (Table 4), 
the inferior field was the only vision factor significantly associated with falls or 
injurious falls.  This association remained significant following adjustment for age, 
gender, use of multifocal spectacle corrections, number of self-reported co-
morbidities and self-rated health status.  In the fully-adjusted model, each unit 
reduction in the inferior field factor at baseline was associated with a 57% higher rate 
of falls (RR 1.57, 95%CI 1.06, 2.32) and an 82% higher rate of injurious falls (RR 
1.80, 95%CI 1.12, 2.98) during the 12-month follow-up.  The acuity, contrast and 
superior field factors were not associated with the rate of falls or injurious falls in any 
of the multivariate models.   
DISCUSSION: 
This study of community-dwelling older adults with glaucoma demonstrated that 
greater visual impairment, particularly binocular inferior visual field loss, was 
associated with an increased risk of prospective falls and injurious falls.  This finding 
is consistent with previous research among population-based cohorts,4, 5  and is the 
first to report a significant link between inferior visual field loss and falls and injurious 
falls exclusively in a cohort of older adults with glaucoma.   
The finding that approximately 44% of the glaucoma participants reported one or 
more falls and over 20% reported two or more falls during the 12-month follow-up is 
consistent with that of previous population studies, although it is difficult to make 
direct comparisons because of variations in cohort characteristics, falls outcomes 
and study designs.  Prospective community-based studies report annual falls rates of 
the order of 30%, and multiple falls of the order of 16%;4, 5 however, there have been 
no previous prospective falls studies of individuals with glaucoma.  In retrospective 
case-control studies, around 35% to 38% of participants with glaucoma reported one 
or more falls in the previous year;20, 45  and approximately 10% of participants 
attending a glaucoma clinic, of whom 70% had a positive diagnosis of glaucoma, 
reported an injurious fall in the previous 12 months which required medical 
attention.23 
Recent studies have reported significant associations between visual field loss and 
prospective falls risk,4, 5 which is consistent with our findings.  Freeman et al5 
reported that every 10 point loss of binocular visual field (identical to the IVF-120 in 
the present study) was associated with an 8% higher odds of falling after adjustment 
for potential confounding factors in their population-based study.  Coleman et al4 
reported that the risk of falling among older women was 50% greater in those with 
severe visual field loss, defined as 20 or more points missed in a binocular visual 
field from a 76-point field screening strategy, compared with those with no visual field 
loss.  In the present study, every 10 points missed on IVF-120 at baseline was 
associated with a 25% higher rate of falls, while every 5dB reduction in IVF-60 at 
baseline was associated with a 47% higher rate of falls.  Comparisons between 
studies are difficult however, due to differences in the visual field assessments, fall 
outcomes, statistical analyses and study populations.   
The inferior field region was shown to be an important predictor of prospective falls in 
the present study, more so than superior field loss.  This is in general agreement 
with Coleman et al4 who reported that the odds of falling among older women with 
severe inferior visual field loss, when compared with no inferior loss, were 91% 
higher, while the odds of falling among those with severe superior visual field loss, 
when compared with no superior visual field loss, were only 74% higher.  The risk of 
falls appeared higher among those with inferior field loss, although Coleman et al4 
did not statistically assess the independent contributions of these field regions to the 
risk of falls.  Freeman and colleagues5 did examine the independent contributions of 
field loss location on prospective falls, however, neither the superior nor inferior field 
areas were found to be stronger predictors in their multivariate models. Importantly, 
Freeman et al5 excluded the central 20 degree radius areas in their calculation of 
inferior and superior field loss in their cohort with a broad range of eye diseases, 
while we included this region in our analysis.   
Our findings highlight the importance of the inferior visual field in negotiating real-
world complex environments.  When walking, people have been shown to fixate 
approximately two steps ahead,46 and the inferior visual field contributes a major 
proportion of visual information used to guide  lower limb movements, foot placement 
and obstacle detection.7  This is supported by studies which report that greater loss 
in the central and inferior visual field areas negatively impact on mobility 
performance among adults with visual impairment.18, 26   
An interesting question, that is relevant to clinical practice, is whether a particular 
visual field assessment strategy better predicts falls outcomes in this population.  
However, our findings failed to provide any evidence that one field strategy was 
superior to the other in terms of predicting these outcomes.  We suspect that this 
was due to the high correlations between the different field tests included in this 
study (r > -0.90).  These findings indicates that routinely measured monocular 24-2 
threshold field tests used for glaucoma assessment and monitoring, when 
considered as an integrated binocular field, are as good at identifying individuals who 
may be at risk of falls as more peripheral screening field tests.   
The use of topical beta-blockers was not found to be associated with prospective 
falls.  Our findings are consistent with a recent retrospective falls study, which found 
that older adults with glaucoma using topical beta-blockers were no more likely to 
report a fall in the previous year than those using topical prostaglandins, 27 and no 
significant association between oral beta-blocker use and falls was shown in 
previous studies.47-49  Although some studies have found an association between 
topical beta-blocker use and falls,9, 23 they failed to consider the confounding effect of 
vision loss in their analyses, as control participants did not use any glaucoma 
medications, thus were unlikely to have glaucomatous visual impairment.  Topical 
beta-blockers remain a common treatment modality for glaucoma and our findings 
suggest that their use poses no additional risk for falls among older adults compared 
to other topical glaucoma medications.     
A strength of this study includes the comprehensive assessment of visual function 
using standard tests, particularly binocular integrated visual fields, in a well-defined 
cohort of older adults with glaucoma.  In addition, falls were collected prospectively, 
which enables the causal relationship between vision loss and falls to be examined 
and is the gold-standard method for accurate falls data.37  The study, however, was 
limited by its relatively small sample size, even though significant and clinically 
meaningful findings were demonstrated.  We cannot exclude the possibility that there 
was some recruitment bias towards higher functioning participants who attended the 
research visits, which may have resulted in conservative estimates of the true 
association between visual impairment and falls; it is possible that the impact of 
glaucomatous visual impairment on falls is even greater in frailer, less independent 
populations. 
The prevention of falls among older adults with glaucoma would benefit from 
increased awareness of the links between visual field loss and falls among patients 
and eye care practitioners.  Although glaucomatous visual impairment is irreversible, 
there may be other options which could assist in reducing falls in this population.  
Possible interventions include promoting behavioral change to reduce risk-taking 
behaviors or modifying other non-vision risk factors for falls, such as physical 
function or environmental factors.  
In conclusion, the findings of the present study and that of other recent studies4, 5, 8 
highlight the importance of screening for visual field loss as an integral component in 
falls risk assessments.  The binocular inferior visual field region was an independent 
predictor of falls and injurious falls, while the remaining components of vision did not 
play a significant role in predicting these outcomes.  The significance of this work is 
that the inferior visual field area is an overlooked and potentially important risk factor 
for falls among older adults.   Given the serious consequences of falls, the significant 
association between visual field loss and falls highlights the need to target potential 
interventions to maintain the independence, health and well-being of older adults 
with glaucoma. 
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TABLES 
Table 1: Glaucoma medical history and visual function characteristics of the study 
cohort (n=71) 
Characteristic Value 
Glaucoma medical history 
 Number of glaucoma topical medications used per person, median (IQR) 1 (1 to 2) 
 Use of one or more topical beta-blocker, n (%) 21 (30%) 
 Time since diagnosis, years, median (IQR) 9 (4 to 15) 
 History of previous glaucoma surgery, n (%) 14 (19%) 
Visual function measures, mean ± SD (range) 
 Visual acuity, logMAR  
    Better-eye 0.06 ± 0.13 (-0.26 to 0.52) 
    Worse-eye 0.20 ± 0.25 (-0.10 to 1.40) 
 Contrast sensitivity, logCS  
    Better-eye 1.54 ± 0.17 (0.65 to 1.70) 
    Worse-eye 1.45 ± 0.26 (0.25 to 1.70) 
 IVF-60, dB  
    Overall field -4.21 ± 6.38 (1.59 to -28.23) 
    Inferior field -3.61 ± 6.38 (2.75 to -28.36) 
    Superior field -4.80 ± 7.13 (3.25 to -28.96) 
 IVF-120, points missed  
    Overall field 32 ± 21 (6 to 96) 
    Inferior field 15 ± 11 (1 to 50) 
    Superior field 17 ± 12 (2 to 46) 
 
SD = standard deviation; IQR = inter-quartile range; IVF = integrated visual field. 
Table 2: Associations of visual function variables and beta-blocker use with number 
of falls and falls with injury, adjusted for age and gender (negative binomial 
regression; N=71) 
  FALLS    INJURIOUS FALLS 
Variable RR (95%CI) P-value   RR (95%CI) P-value 
Visual acuity, per line missed 
 better-eye 1.32 (1.07-1.64) 0.009  1.17 (0.89-1.56) 0.26 
 worse-eye 1.15 (1.03-1.28) 0.01  1.03 (0.86-1.23) 0.75 
Contrast sensitivity, per triplet missed 
 better-eye 1.11 (1.03-1.20) 0.005  1.05 (0.93-1.18) 0.43 
 worse-eye 1.08 (1.02-1.13) 0.006  1.04 (0.95-1.12) 0.40 
IVF-60, per 5dB reduction 
 overall field 1.47 (1.16-1.87) 0.001  1.36 (0.98-1.89) 0.07 
 inferior field 1.56 (1.22-1.99) <0.001  1.47 (1.08-2.02) 0.016 
 superior field 1.32 (1.06-1.65) 0.012  1.17 (0.85-1.61) 0.33 
IVF-120, per 10 points missed 
 overall field 1.25 (1.08-1.44) 0.002  1.24 (1.01-1.52) 0.037 
 inferior field 1.62 (1.23-2.14) 0.001  1.62 (1.10-2.37) 0.014 
  superior field 1.39 (1.06-1.81) 0.016  1.31 (0.90-1.90) 0.16 
Use of any topical beta-blocker medication (reference: no) 
 Yes 0.76 (0.39-1.48) 0.42  0.57 (0.24-1.37) 0.21 
 
RR = rate ratio; CI = confidence interval; IVF = integrated visual field; dB decibel 
Table 3: The loading of the visual function variables on the four vision factors 
(principal components factors analysis with varimax transformation; n=71) 
 Factor 1 - 
Acuity 
Factor 2 - 
Contrast 
Factor 3 – 
Inferior field 
Factor 4 – 
Superior field 
Visual acuity, better-eye‡ 0.92 -0.24 -0.20 -0.12 
Visual acuity, worse-eye‡ 0.63 -0.58 -0.24 -0.26 
Contrast sensitivity, better-
eye† -0.32 0.79 0.31 0.34 
Contrast sensitivity, worse-
eye† -0.30 0.80 0.33 0.35 
IVF-60, inferior field† -0.32 0.39 0.74 0.39 
IVF-60, superior field† -0.21 0.35 0.33 0.83 
IVF-120, inferior field‡ 0.21 -0.29 -0.82 -0.42 
IVF-120, superior field‡ 0.13 -0.27 -0.34 -0.88 
% Variance explained 
(rotated solution)§ 20.5 26.0 21.7 26.4 
 
Factor loadings >0.60 are in bold; IVF = integrated visual field 
† Higher scores represent better visual performance 
‡ Lower scores represent better visual performance 
§ The four rotated factors together represented 94.6% of the total variance 
 
Table 4: Variables in multivariate models predicting the number of falls and falls with 
injury (negative binomial regression; N=71)  
    FALLS 
  
Model A† Model B‡ Model C§ 
  
RR (95%CI) P-value RR (95%CI) P-value RR (95%CI) P-value 
Vision factors (per unit reduction in performance) 
 
Acuity 1.19 (0.82-1.73) 0.36 1.18 (0.81-1.72) 0.40 1.29 (0.81-2.03) 0.28 
 
Contrast  1.19 (0.90-1.56) 0.21 1.26 (0.94-1.68) 0.12 1.14 (0.82-1.60) 0.44 
 
Inferior field 1.68 (1.22-2.30) 0.001 1.75 (1.24-2.47) 0.001 1.57 (1.06-2.32) 0.024 
 
Superior field 0.81 (0.52-1.25) 0.35 0.90 (0.56-1.43) 0.65 0.89 (0.52-1.54) 0.69 
Age (per year) __ 
 
1.04 (0.97-1.10) 0.28 1.04 (0.97-1.11) 0.31 
Gender (Reference: Male) 
 
Female __ 
 
2.11 (0.95-4.69) 0.07 1.96 (0.86-4.44) 0.11 
Multifocal spectacle wearer (Reference: No) 
 
Yes __ 
 
__ 
 
1.83 (0.73-4.60) 0.20 
Number of co-morbidities (Reference: None) 
 
1 __ 
 
__ 
 
1.25 (0.35-4.46) 0.73 
 
2 __ 
 
__ 
 
1.31 (0.33-5.12) 0.70 
 
3 or more __ 
 
__ 
 
0.71 (0.23-2.17) 0.55 
Self-rated health (Reference: Excellent) 
     
 
Very good __ 
 
__ 
 
1.60 (0.24-10.6) 0.63 
 
Good __ 
 
__ 
 
1.35 (0.21-8.78) 0.76 
 
Fair __ 
 
__ 
 
2.82 (0.34-23.5) 0.34 
  
  
    INJURIOUS FALLS 
  
Model A† Model B‡ Model C§ 
  
RR (95%CI) P-value RR (95%CI) P-value RR (95%CI) P-value 
Vision factors (per unit reduction in performance) 
 
Acuity 1.09 (0.71-1.66) 0.70 1.07 (0.69-1.67) 0.75 1.08 (0.65-1.77) 0.77 
 
Contrast  0.77 (0.46-1.29) 0.32 0.85 (0.50-1.45) 0.56 0.73 (0.40-1.34) 0.31 
 
Inferior field 1.58 (1.10-2.27) 0.013 1.85 (1.21-2.83) 0.004 1.82 (1.12-2.98) 0.016 
 
Superior field 0.92 (0.57-1.50) 0.75 1.03 (0.59-1.78) 0.92 1.00 (0.54-1.85) 0.99 
Age (per year) __ 
 
1.01 (0.93-1.09) 0.89 0.99 (0.90-1.08) 0.79 
Gender (Reference: male) 
 
Female __ 
 
2.95 (1.06-8.25) 0.039 3.08 (1.03-9.24) 0.045 
Multifocal spectacle wearer (Reference: No) 
 
Yes __ 
 
__ 
 
1.22 (0.40-3.68) 0.73 
Number of co-morbidities (Reference: None) 
 
1 __ 
 
__ 
 
0.76 (0.16-3.72) 0.74 
 
2 __ 
 
__ 
 
1.47 (0.28-7.62) 0.65 
 
3 or more __ 
 
__ 
 
0.93 (0.22-3.95) 0.92 
Self-rated health (Reference: Excellent) 
     
 
Very good __ 
 
__ 
 
0.65 (0.08-5.22) 0.69 
 
Good __ 
 
__ 
 
0.66 (0.09-5.16) 0.70 
  Fair __   __   1.68 (0.16-17.5) 0.66 
 
RR = rate ratio; CI = confidence interval;  
† Model A: Adjusted for all vision factors 
‡ Model B: Adjusted for all vision factors, age and gender 
§ Model C: Adjusted for all vision factors, age, gender, multifocal use, number of co-
morbidities and self-rated health 
 
 
